Start-Up Delivers Liquid Replenishment for Pregnancy Sickness

Why It Matters

The supplement fills a market gap for safe, easily ingestible nutrition in pregnancy, potentially improving outcomes for women with severe nausea and reducing hospital visits.

Key Takeaways

• Replenish offers 28 ml sachets with electrolytes, vitamins, methylfolate
• Founded by Laura Milward, who suffered Hyperemesis Gravidarum
• Available direct‑to‑consumer and on Amazon since April 2026
• Partners with Pregnancy Sickness Support, donating a profit percentage
• Midwives suggest line extensions, including a labour‑stage formula

Pulse Analysis

Nausea affects roughly 90% of pregnant women, yet existing prenatal supplements often come in large capsules or powders that can trigger gag reflexes, especially for those with Hyperemesis Gravidarum. Traditional options rely on strong flavours or high sugar content, leaving a sizable underserved segment that struggles to maintain adequate electrolyte and vitamin intake. Health professionals have long lacked targeted solutions, and recent UK care pathways only began addressing pregnancy‑related nausea a year and a half ago, underscoring the urgency for innovative nutrition products.

Replenish enters the market with a 28 ml lemon‑flavoured liquid that combines glucose, key electrolytes (sodium, potassium, magnesium, chloride) and a suite of vitamins, including bio‑available methylfolate. Co‑founders Laura Milward, drawing on personal Hyperemesis Gravidarum experience, and marketing specialist Laura Moore assembled an advisory board spanning medicine, nutrition and midwifery to fine‑tune the formula. Launched in April 2026, the product is sold directly to consumers and via Amazon, and its partnership with Pregnancy Sickness Support channels profits back to the charity while granting access to a dedicated patient community. Early feedback highlights the drink’s tolerability, with some patients reporting it as the sole source of nutrition they could keep down during severe vomiting episodes.

The launch signals a broader shift toward niche, condition‑specific prenatal care, a segment projected to grow as awareness of pregnancy‑related disorders rises. By addressing a clear clinical need, Replenish not only opens a revenue stream in the UK supplement market but also offers a template for collaborations between start‑ups, charities and healthcare providers. If adoption expands, the product could reduce emergency visits, lower healthcare costs associated with severe nausea, and inspire further line extensions—such as formulations for labour—thereby cementing its role in modern maternal health ecosystems.